Weight loss injections like Ozempic, Wegovy, and Mounjaro have revolutionized the obesity fight, helping millions of Americans shed stubborn pounds, lower their blood sugar, and reduce their risk of ...

In the second part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, explains how dual-action metabolic therapies can address clinical or tolerability gaps observed in ...

Indian equities rebounded in Q2 2025 amid rate cuts and capex surge. Explore how Baron India Fund is positioned for growth; ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

Frequent alcohol consumption is linked to more than 20 health conditions, including stroke, hypertension and cardiovascular disease. The effects are often delayed by two years or more, which can make ...

Consumers are the only ones struggling to pay the rising prices of popular GLP-1 drugs, as states like Connecticut see ...

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.